Inhibition of tumour necrosis factor-alpha by antisense targeting produces immunophenotypical and morphological

Damien D Pearse1, Francisco C Pereira, Anna Stolyarova

  • 1The Miami Project to Cure Paralysis, University of Miami School of Medicine, PO Box 016960 (R-48), Miami, FL 33101, USA. DPearse@miamiproject.med.miami.edu

Insights

Tumor necrosis factor-alpha (TNF-alpha) contributes to sustained microglial activation following spinal cord injury. Blocking TNF-alpha with antisense deoxyoligonucleotides (ASOs) reversed microglial activation, suggesting a potential therapeutic target.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglia exhibit stereotypical responses to pathology, involving morphological and immunophenotypical changes.
  • These activated microglia release factors that modify their environment and potentially sustain their activation state.

Purpose of the Study:

  • To investigate the role of microglial-produced tumor necrosis factor-alpha (TNF-alpha) in maintaining microglial activation post-spinal cord injury.
  • To assess the efficacy of selective TNF-alpha inhibition using antisense deoxyoligonucleotides (ASOs) in modulating microglial activation.

Main Methods:

  • Microglia and macrophages were isolated from contused rat spinal cords.
  • Cells were characterized morphologically and immunophenotypically (GSA-IB4, OX-42, ED-1, IIA).
  • TNF-alpha production was measured, and the effects of TNF-alpha ASOs on cell activation and morphology were evaluated.

Main Results:

  • Activated microglia/macrophages from injured spinal cords exhibited rounded morphology and expressed high levels of GSA-IB4, OX-42, ED-1, and IIA.
  • These cells secreted significant amounts of TNF-alpha.
  • Treatment with TNF-alpha ASOs efficiently reduced TNF-alpha production and induced a shift in cell morphology towards spindle and stellate shapes.
  • ASO treatment also led to decreased expression of ED-1 and IIA markers, indicating reduced activation.

Conclusions:

  • Early TNF-alpha secretion by microglia/macrophages may contribute to their autoactivation after spinal cord injury.
  • Microglial/macrophage activation at the peak of injury is not a stable state and can be reversed by blocking TNF-alpha.
  • Targeting TNF-alpha represents a potential strategy for modulating microglial responses in spinal cord injury.

Related Concept Videos